Alaunos Therapeutics, Inc. - Common stock (TCRT)

CUSIP: 98973P309

Q2 2024 13F Holders as of 30 Jun 2024

Type / Class
Equity / Common stock
Shares outstanding
2,198,384
Total 13F shares
37
Share change
+37
Total reported value
$25
Price per share
$0.68
Number of holders
3
Value change
+$25
Number of buys
3

Quarterly Holders Quick Answers

What is CUSIP 98973P309?
CUSIP 98973P309 identifies TCRT - Alaunos Therapeutics, Inc. - Common stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of TCRT - Alaunos Therapeutics, Inc. - Common stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
MSD Partners, L.P.
13F
Company
class O/S missing
1,010,101
$1,828,283 31 Mar 2024
13F
VANGUARD GROUP INC
13F
Company
class O/S missing
629,148
$1,138,758 31 Mar 2024
13F
BlackRock Finance, Inc.
13F
Company
class O/S missing
222,440
$402,616 31 Mar 2024
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
class O/S missing
150,417
$272,318 31 Mar 2024
13F
Kevin S. Boyle Sr.
3/4/5
Chief Executive Officer, Director
class O/S missing
798,236
$111,993 01 Sep 2023
STATE STREET CORP
13F
Company
class O/S missing
50,331
$91,099 31 Mar 2024
13F
OSAIC HOLDINGS, INC.
13F
Company
class O/S missing
33,629
$60,866 31 Mar 2024
13F
COMMERCE BANK
13F
Company
class O/S missing
29,132
$52,728 31 Mar 2024
13F
NORTHERN TRUST CORP
13F
Company
class O/S missing
29,034
$52,552 31 Mar 2024
13F
Raffaele Baffa
3/4/5
Chief Medical Officer
class O/S missing
280,645
$39,374 17 May 2021
MORGAN STANLEY
13F
Company
class O/S missing
17,095
$30,941 31 Mar 2024
13F
Allred Capital Management, LLC
13F
Company
class O/S missing
16,866
$30,527 31 Mar 2024
13F
UBS Group AG
13F
Company
class O/S missing
16,190
$29,305 31 Mar 2024
13F
Virtu Financial LLC
13F
Company
class O/S missing
15,440
$28,000 31 Mar 2024
13F
MAGNOLIA CAPITAL ADVISORS LLC
13F
Company
class O/S missing
24,695
$27,658 31 Mar 2024
13F
CIBC Private Wealth Group LLC
13F
Company
class O/S missing
14,666
$25,666 31 Mar 2024
13F
Fortis Group Advisors, LLC
13F
Company
class O/S missing
13,999
$25,338 31 Mar 2024
13F
GROUP ONE TRADING LLC
13F
Company
class O/S missing
13,444
$24,334 31 Mar 2024
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
class O/S missing
12,993
$23,517 31 Mar 2024
13F
Heidi Hagen
3/4/5
Director
class O/S missing
145,889
$20,468 02 Sep 2021
Atria Wealth Solutions, Inc.
13F
Company
class O/S missing
11,145
$20,172 31 Mar 2024
13F
Federation Des Caisses Desjardins du Quebec
13F
Individual
class O/S missing
9,914
$17,944 31 Mar 2024
13F
WELLS FARGO & COMPANY/MN
13F
Company
class O/S missing
7,138
$12,920 31 Mar 2024
13F
Sugarloaf Wealth Management, LLC
13F
Company
class O/S missing
4,365
$7,901 31 Mar 2024
13F
BNP PARIBAS FINANCIAL MARKETS
13F
Company
class O/S missing
3,459
$6,261 31 Mar 2024
13F
Christopher Bowden
3/4/5
Director
mixed-class rows
144,167
mixed-class rows
$6,197 22 Jun 2022
Tower Research Capital LLC (TRC)
13F
Company
class O/S missing
3,231
$5,848 31 Mar 2024
13F
AdvisorNet Financial, Inc
13F
Company
class O/S missing
2,821
$5,106 31 Mar 2024
13F
Steward Partners Investment Advisory, LLC
13F
Company
class O/S missing
2,310
$4,181 31 Mar 2024
13F
BANK OF AMERICA CORP /DE/
13F
Company
class O/S missing
1,540
$2,788 31 Mar 2024
13F
SIMPLEX TRADING, LLC
13F
Company
class O/S missing
865
$1,000 31 Mar 2024
13F
NBC SECURITIES, INC.
13F
Company
class O/S missing
200
$1,000 31 Mar 2024
13F
HARBOUR INVESTMENTS, INC.
13F
Company
class O/S missing
466
$843 31 Mar 2024
13F
RHUMBLINE ADVISERS
13F
Company
class O/S missing
424
$766 31 Mar 2024
13F
Newbridge Financial Services Group, Inc.
13F
Company
class O/S missing
252
$456 31 Mar 2024
13F
Key FInancial Inc
13F
Company
class O/S missing
245
$443 31 Mar 2024
13F
SIGNATUREFD, LLC
13F
Company
class O/S missing
233
$422 31 Mar 2024
13F
Qube Research & Technologies Ltd
13F
Company
class O/S missing
105
$190 31 Mar 2024
13F
WEST PACES ADVISORS INC.
13F
Company
class O/S missing
100
$181 31 Mar 2024
13F
PFS Partners, LLC
13F
Company
class O/S missing
66
$120 31 Mar 2024
13F
PSI Advisors, LLC
13F
Company
class O/S missing
66
$119 31 Mar 2024
13F
Sound Income Strategies, LLC
13F
Company
class O/S missing
48
$87 31 Mar 2024
13F
Tidemark, LLC
13F
Company
class O/S missing
26
$47 31 Mar 2024
13F
HARBOR INVESTMENT ADVISORY, LLC
13F
Company
class O/S missing
25
$45 31 Mar 2024
13F
TUCKER ASSET MANAGEMENT LLC
13F
Company
class O/S missing
13
$24 31 Mar 2024
13F
JPMORGAN CHASE & CO
13F
Company
class O/S missing
12
$22 31 Mar 2024
13F
CENTRAL TRUST Co
13F
Company
class O/S missing
10
$19 31 Mar 2024
13F
Truvestments Capital LLC
13F
Company
class O/S missing
1
$2 31 Mar 2024
13F
Eleanor de Groot
3/4/5
EVP, Operations
class O/S missing
350,000
30 Mar 2022
Abhishek K. Srivastava
3/4/5
Vice President, Technical Operations
class O/S missing
125,000
15 Mar 2023

Institutional Holders of Alaunos Therapeutics, Inc. - Common stock (TCRT) as of Q2 2024

As of 30 Jun 2024, Alaunos Therapeutics, Inc. - Common stock (TCRT) was held by 3 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 37 shares. The largest 3 holders included HARBOR INVESTMENT ADVISORY, LLC, Family Firm, Inc., and Ashton Thomas Private Wealth, LLC. This page lists 3 institutional shareholders reporting positions in this security for the Q2 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2024 vs Q4 2025 Across Filers

Q4 2025 holders
26
Q2 2024 holders
3
Holder diff
-23
Investor Q4 2025 Shares Q2 2024 Shares Share Diff Share Chg % Q4 2025 Value $ Q2 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .